secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2025-12-30T23:59:59+00:00
Accession:  0001493152-25-029634
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic closes initial $800K convertible note offering at 12% with warrants
-----------------------------------------------------------------------------

- Issued 32 units at $25,000 each to 21 accredited investors; total $800,000 raised.
- Each unit consists of a 2-year 12% note convertible into Oncotelic stock at $0.10/share or EdgePoint AI stock at $1.00/share.
- Each unit also includes warrants to buy 250,000 Oncotelic shares at $0.12 or 25,000 EdgePoint warrants at $1.25.
- Offering allows up to 500 units ($12.5M); prior 2023 PPM note exchanged as part of deal.
- Registration rights granted for shares issuable under the units and warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315225029634/0001493152-25-029634-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315225029634/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-029634

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer